In vivo Efficacy Studies in Cell Line and Patient-derived Xenograft Mouse Models
2017
Elizabeth Tovar | Curt Essenburg | Carrie Graveel
In vivo xenograft models derived from human cancer cells have been a gold standard for evaluating the genetic drivers of cancer and are valuable preclinical models for evaluating the efficacy of cancer therapeutics. Recently, patient-derived tumorgrafts from multiple tumor types have been developed and shown to more accurately recapitulate the molecular and histological heterogeneity of cancer. Here we detail the procedures for developing patient-derived xenograft models from breast cancer tissue, cell-based xenograft models, serial tumor transplantation, tumor measurement, and drug treatment.
Show more [+] Less [-]Bibliographic information
This bibliographic record has been provided by Directory of Open Access Journals